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General Experimental Procedure and Reagent Availability 
 
All manipulations were carried out under an inert atmosphere using an argon-filled glovebox or 
standard Schlenk techniques. All glassware was oven dried prior to use. All solvents were 
anhydrous grade. All reagents, unless specified, were obtained from commercial sources and 
used without further purification. 
1
H, 
13
C{
1
H}, 
31
P{
1
H}, and 
19
F{
13
C} NMR spectra were 
obtained at 400, 101, 162 and 376 MHz respectively. 
1
H NMR spectra were recorded relative to 
residual protio-solvent.
 13
C{
1
H} NMR spectra were recorded relative to the solvent resonance. 
31
P{
1
H} and 
19
F{
13
C} NMR spectra were recorded relative to external standards (85% 
phosphoric acid and trifluoroacetic acid). 1
1
 and trans-1,4-diacetoxy-2-butene
2
 were prepared as 
previously published. Preparations of N,N'-bis(2,6-difluorophenyl)formimidamide
3
 and 1,3-
bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate
4
 have 
been detailed in the literature but are included for completeness.  
 
Preparation of 2 [(1,3-bis-(2,6-diisopropylphenyl)-2-imidazolidinylidene)(3,6-dichloro-1,2-
benzenedithiolato)(o-isopropoxyphenylmethylene)ruthenium] 
 
In an argon filled glovebox, a 40 mL scintillation vial equipped with a magnetic stirbar was 
charged with C711 (0.500 g, 0.703 mmol), (3,6-dichlorobenzene-1,2-dithiolato)
(ethylenediamine)zinc(II) (0.259 g, 0.774 mmol), and 15 mL THF. The resulting suspension was 
stirred for 6 hours at room temperature then devolatilized. The resulting residue was redissolved 
in a minimal amount of dichloromethane, filtered through a pad of celite, devolatilized and 
recrystallized from dichloromethane/diethyl ether at -35 ºC. The red/brown crystals were isolated 
by filtration then dried in vacuo to afford 2 (0.462 g, 77.4% yield).  
 
1
H NMR (400 MHz, CD2Cl2) δ 14.52 (s, 1H), 7.52-7.34 (m, 4H), 7.31 (d, J = 6.8 Hz, 1H), 7.20 
(d, J = 6.4 Hz, 1H), 6.97-6.86 (m, 2H), 6.82 (t, J = 7.3 Hz, 2H), 6.74 (d, J = 7.0 Hz, 1H), 6.55 (d, 
J = 6.3 Hz, 1H), 4.97 (hept, J = 5.6 Hz, 1H), 4.36 (dd, J = 20.2, 10.5 Hz, 1H), 4.18 (dd, J = 19.1, 
9.4 Hz, 1H), 4.02 (dd, J = 17.6, 9.5 Hz, 1H), 3.96-3.80 (m, 3H), 3.21 – 2.99 (m, 1H), 2.54-2.34 
(m, 1H), 1.91 (d, J = 5.5 Hz, 3H), 1.43 (d, J = 5.8 Hz, 3H), 1.38 (d, J = 5.9 Hz, 3H), 1.20-1.35 
(m, 6H), 1.00-1.10 (m, 6H), 0.94 (d, J = 5.9 Hz, 3H), 0.54 (d, J = 5.6 Hz, 3H), 0.04 (d, J = 5.4 
Hz, 3H). 
13
C NMR (101 MHz, CD2Cl2) δ 260.6 (d, J = 9.5 Hz), 220.3, 156.0, 153.8, 149.6, 148.9, 147.3, 
145.7, 143.1, 141.9, 138.8, 136.1, 131.4, 130.6, 130.1, 129.2, 129.1, 126.0, 126.0, 125.6, 125.4, 
124.5, 123.5, 122.9, 121.9, 115.0, 76.5, 54.4, 54.4, 30.1, 29.5, 29.1, 28.8, 27.5, 27.3, 26.7, 26.1, 
26.1, 24.2, 23.4, 21.9, 21.2, 20.4. 
HRMS (FAB+): [M]
+
 C43H52Cl2N2ORuS2 Calculated – 848.1942, Found – 848.1960 
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ORTEP diagram of 2 
 
Preparation of N
1
,N
2
-bis(2-fluoro-6-methylphenyl)oxalamide 
 
To a 500 mL round bottom flask equipped with a magnetic stirbar was added 2-methyl-6-
fluoroaniline (15.0 mL, 130 mmol), tetrahydrofuran /water (1:1, 200 mL), sodium hydroxide 
(5.19 g, 130 mmol), and triethylamine (0.90 mL, 6.5 mmol). The suspension was stirred 
vigorously at 0 ºC and oxalyl chloride (6.58 mL, 77.8 mmol) was added dropwise. After 
complete addition the reaction was stirred for 1 hour while warming to ambient temperature. The 
resulting solid was isolated by filtration, washed with 1M HCl (50 mL), water (3 x 50 mL), and 
diethyl ether (2 x 50 mL) then dried in vacuo to afford N
1
,N
2
-bis(2-fluoro-6-
methylphenyl)oxalamide (7.05 g, 35.7% yield). 
 
1
H NMR (400 MHz, DMSO-d6) δ 10.52 (s, 2H), 7.32-7.24 (m, 2H), 7.19-7.11 (m, 4H), 2.24 (s, 
6H). 
13
C NMR (101 MHz, DMSO-d6) (peak list) δ 158.8, 158.7, 156.4, 137.8, 137.8, 128.4, 128.3, 
125.9, 125.8, 123.1, 123.0, 113.4, 113.2, 17.6, 17.6. 
19
F NMR (376 MHz, DMSO-d6) (peak list) δ -120.22, -120.23, -120.24, -120.26. 
HRMS (FAB+): [M+H]
+
 C16H15F2N2O2 Calculated – 305.1102, Found – 305.1090 
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Preparation of 1,3-bis(2-fluoro-6-methylphenyl)-4,5-dihydro-1H-imidazol-3-ium chloride 
 
In an argon filled glovebox, lithium aluminum hydride (3.74 g, 98.6 mmol) and tetrahydrofuran 
/toluene (1:1, 100 mL) were combined in a 500 mL round bottom flask equipped with a magnetic 
stirbar. N
1
,N
2
-bis(2-fluoro-6-methylphenyl)oxalamide (6.00 g, 19.7 mmol) was subsequently 
added to the suspension in small portions with stirring. The reaction was sealed, removed from 
the glovebox, fitted with a reflux condenser and heated to 50 ºC under argon for 12 h. After 
cooling to ambient temperature the reaction was quenched by slowly adding water (3.8 mL), 
followed by aqueous sodium hydroxide (15 wt%, 3.8 mL), then an additional portion of water 
(11.4 mL).  The reaction was stirred rapidly for 2 hours then decanted away from solid residues 
and dried over magnesium sulfate. Filtration through a pad of celite afforded a clear solution 
which was combined with a hydrochloric acid (2.0 M in ether, 30 mL, 60 mmol). The resulting 
precipitate was isolated by filtration then combined with triethyl orthoformate (30 mL) and 
heated to 130 ºC for 1 hour. After cooling the reaction to ambient temperature, the precipitate 
was isolated by filtration, washed with diethyl ether (2 x 25 mL), hexanes (2 x 50 mL), then 
dried in vacuo to afford 1,3-bis(2-fluoro-6-methylphenyl)-4,5-dihydro-1H-imidazol-3-ium 
chloride (4.56 g, 71.7% yield) 
 
1
H NMR (400 MHz, DMSO-d6) δ 9.63 (s, 1H), 7.55-7.47 (m, 2H), 7.38 (t, J = 9.2 Hz, 2H), 7.31 
(d, J = 7.8 Hz, 2H), 4.57 (s, 4H), 2.48 (s, 6H). 
13
C NMR (101 MHz, DMSO-d6) (peak list) δ 161.6, 158.7, 156.2, 137.9, 131.5, 131.4, 127.2, 
127.1, 122.5, 122.3, 114.4, 114.2, 51.8, 51.8, 17.1, 17.1. 
19
F NMR (376 MHz, DMSO-d6) (peak list) δ -122.06, -122.08, -122.09, -122.10. 
HRMS (FAB+): [M]
+
 C17H17F2N2 Calculated – 287.1360, Found – 287.1367 
 
Preparation of C829 [(1,3-Bis(2-fluoro-6-methylphenyl)-2-
imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium 
 
 
In an argon filled glovebox, C823 (0.676 g, 0.822 mmol), 1,3-bis(2-fluoro-6-methylphenyl)-4,5-
dihydro-1H-imidazol-3-ium chloride (0.500 g, 1.64 mmol) and toluene (50 mL) were combined 
in a 250 mL round bottom flask equipped with a magnetic stirbar. A solution of potassium 
bis(trimethylsilyl)amide (0.328 g, 1.64 mmol) in toluene (20 mL) was subsequently added and 
the solution stirred at ambient temperature for 2 hours. All volatiles were subsequently removed 
in vacuo. The resulting residue was redissolved in dichloromethane (10 mL), filtered through a 
pad of celite, and devolatilized.  The crude product was triturated with hexanes (2 x 20 mL) then 
recrystallized from toluene/hexanes at ambient temperature. The red/brown crystalline complex 
was isolated by filtration and dried in vacuo to afford C829 (0.454 g, 66.7% yield)  
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1
H NMR (400 MHz, CD2Cl2) δ 19.28 (s, 1H), 9.4-8.0 (br s 1H), 7.41-7.30 (m, 2 H). 7.20 (d, J = 
7.6 Hz, 1H), 7.16-7.04 (m, 3H), 6.90-5.80 (br s, 3H), 6.72-6.62 (m, 1H), 4.22-3.75 (m, 4H), 2.75 
(pseudo d, J = 16.5 Hz, 3H), 2.55-2.05 (br s, 3H), 2.11 (pseudo dd, J = 22.7, 11.9 Hz, 3H), 1.65-
1.23 (m, 15H), 1.10-0.72 (m, 15H). 
31
P NMR (162 MHz, CD2Cl2) δ 28.5 (s). 
19
F NMR (376 MHz, CD2Cl2) (peak list) δ -110.7 (br s), -111.7 (br s), -119.7 (br s), -120.4. 
HRMS (FAB+): [M]
+
 C42H55Cl2F2N2PRu Calculated – 828.2492, Found – 828.2493. 
 
Preparation of 3 [(1,3-bis-(2-fluoro-6-methylphenyl)-2-imidazolidinylidene)(3,6-dichloro-1,
2-benzenedithiolato)(o-isopropoxyphenylmethylene)ruthenium] 
 
In an argon filled glovebox, C829 (0.300 g, 0.362 mmol), 1-isopropoxy-2-(prop-1-en-1-
yl)benzene (0.638 g, 3.62 mmol) and toluene (10 mL) were combined in a 40 mL scintillation 
vial equipped with a magnetic stirbar. The reaction was stirred at ambient temperature for 14 
hours then directly adsorbed onto silica gel.  Purification by column chromatography (silica gel, 
2 to 6 % gradient of ethyl acetate / hexanes) afforded 0.190 g (90% pure by NMR spectroscopy) 
of crude intermediate.  The impure intermediate was subsequently combined with (3,6-
dichlorobenzene-1,2-dithiolato)(ethylenediamine)zinc(II) (0.115 g, 0.345 mmol) and 
tetrahydrofuran (5 mL) in a 20 mL scintillation vial equipped with a magnetic stirbar. After 4 
hours of stirring at ambient temperature, all volatiles were removed, the residue redissolved in 
dichloromethane, filtered through celite, devolatilized and recrystallized from 
dichloromethane/diethyl ether at -35 ºC. The resulting yellow/brown crystals were isolated by 
filtration, washed with cold diethyl ether (2 x 5 mL) then dried in vacuo to afford 3 (0.116 g, 
35.7% yield)  
 
1
H NMR (400 MHz, CD2Cl2) [three conformers in solution, 8:25:67] δ 14.42 (s, 0.08H), 14.39 
(s, 0.25H), 14.36 (s, 0.67H), 7.37-7.27 (m, 1H), 7.26-7.02 (m, 2.7H), 7.02-6.62 (m, 7.3H), 6.41 
(s, 0.4H), 6.10 (t, J = 9.0 Hz, 0.6H), 5.47-5.38 (m, 1H), 4.13-3.86 (m, 4H), 2.61-2.40 (m, 5H), 
1.85-1.65 (m, 7H). 
19
F NMR (376 MHz, CD2Cl2) (peak list) -118.7 (br s), -119.6 (br s), -120.4 (br s), -123.8 -  
-123.9 (m). 
HRMS (FAB+): [M]
+
 C33H30Cl
37
ClF2N2ORuS2 Calculated – 746.0159, Found – 746.0132 
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Preparation of N,N'-bis(2,6-difluorophenyl)formimidamide 
 
 
To a 100 mL round bottom flask equipped with a magnetic stirbar was added 2,6-difluoroaniline 
(10.0 mL, 95.9 mmol) and triethyl orthoformate (8.11 mL, 48.8 mmol). To the stirring solution 
was added hydrochloric acid (0.040 mL, 12 M, 0.48 mmol) and the reaction stirred at ambient 
temperature for 10 minutes. The reaction solidified and was subsequently sonicated for an 
additional 10 minutes. The resulting precipitate was subsequently isolated by filtration, washed 
with hexanes (2 x 30 mL) then dried in vacuo to afford N,N'-bis(2,6-
difluorophenyl)formimidamide (8.47 g, 67.9% yield). 
 
1
H NMR (400 MHz, DMSO-d6) δ 9.47 (br s, 1H), 8.03 (s, 1H), 7.10 (br s, 6H). 
19
F NMR (376 MHz, DMSO-d6) δ -117.1 (br s, 1F), -125.3 (br s, 3F). 
 
Preparation of 1,3-bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-dihydro-1H-imidazol-3-ium 
tetrafluoroborate 
 
 
To a 250 mL round bottom flask equipped with a magnetic stirbar was added N,N'-bis(2,6-
difluorophenyl)formimidamide (4.00 g, 14.9 mmol), 3-bromo-2-methylpropene (1.65 mL, 16.4 
mmol), and chlorobenzene (120 mL). The reaction was heated to 125 ºC for 24 h. After cooling 
the resulting precipitate was isolated by filtration and washed with diethyl ether (2 x 20 mL). The 
crude product was then partitioned between dichloromethane and an aqueous sodium 
tetrafluoroborate solution (100 mL, 1:1, 2.0 g NaBF4/50 mL). The organic layer was separated, 
dried over magnesium sulfate, filtered through celite and all volatiles were removed by rotary 
evaporation. The resulting reside was recrystallized from dichloromethane/diethyl ether to afford 
1,3-bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate (3.25 
g, 53.1% yield). 
 
1
H NMR (400 MHz, DMSO-d6) δ 9.59 (s, 1H), 7.79 (m, 1H), 7.70-7.60 (m, 1H), 7.55-7.42 (m, 
4H), 4.55 (s, 2H), 1.54 (s, 6H). 
13
C NMR (101 MHz, DMSO-d6) (peak list) δ  161.6, 159.9, 159.8, 157.7, 157.7, 157.3, 157.3, 
155.2, 155.2, 133.9, 133.8, 133.7, 131.7, 131.6, 131.5, 113.3, 113.3, 113.2, 113.2, 113.2, 113.2, 
113.1, 113.1, 113.0, 113.0, 113.0, 109.4, 109.3, 109.1, 71.5, 62.5, 62.5, 62.5, 40.2, 39.9, 39.7, 
39.5, 39.3, 39.1, 38.9, 24.5. 
19
F NMR (376 MHz, DMSO-d6) (peak list) -116.4 (pseudo triplet, J = 7.9 Hz, 2F), -119.8 
(pseudo triplet, J = 8.3 Hz, 2F), -148.3 (s, 4F). 
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Preparation of C642 [(1,3-bis-(2,6-difluorophenyl)-4,4-dimethyl-2-
imidazolidinylidene)dichloro(o-isopropoxyphenylmethylene)ruthenium] 
 
In an argon filled glovebox, 1,3-bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-dihydro-1H-imidazol-
3-ium tetrafluoroborate (0.500 g, 1.22 mmol), sodium tert-butoxide (0.117 g, 1.22 mmol), and 
C823 (0.502 g, 0.610 mmol) were weighed into separate 40 mL scintillation vials equipped with 
magnetic stirbars and each dissolved/suspended in tetrahydrofuran (10 mL). The 
solutions/suspensions were cooled to -35 ºC then the solution of sodium tert-butoxide was added 
to the solution of 1,3-bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-dihydro-1H-imidazol-3-ium 
tetrafluoroborate over 2 minutes. The reaction was stirred at -35 ºC for 1h then combined with 
the chilled suspension of C823 and stirred for an additional hour at -35 ºC before allowing the 
reaction to slowly warm to ambient temperature overnight. The reaction was subsequently 
devolatilized, triturated with hexanes (2 x 40 mL), redissolved in toluene (10 mL), and filtered 
through celite. The crude solution was combined with a solution of 1-isopropoxy-2-(prop-1-en-1-
yl)benzene (0.400 g, 2.27 mmol) in toluene (2 mL) and stirred overnight at ambient temperature.  
The resulting green precipitate was isolated by filtration, washed with toluene/hexanes (1:3, 2 x 
10 mL) then dried in vacuo to afford C642 (0.221 g, 56.4% yield). 
 
1
H NMR (400 MHz, CD2Cl2) δ 16.76 (s, 1H), 7.59-7.54 (m, 1H), 7.53-7.41 (m, 2H), 7.17-7.07 
(m, 5H), 6.98-6.90 (m, 2H), 5.07-4.96 (sept, J = 6.2 Hz, 1H), 4.06 (s, 2H), 1.49 (s, 3H), 1.48 (s, 
3H), 1.42 (d, J = 6.1 Hz, 6H). 
19
F NMR (376 MHz, CD2Cl2) -107.7 (s, 2F), -114.4 (pseudo triplet, J = 6.0 Hz, 2F). 
HRMS (FAB+): [M]
+
 C27H26Cl2F4N2ORu Calculated – 642.0402, Found – 642.0421 
 
Preparation of 4 [(1,3-bis-(2,6-difluorophenyl)-4,4-dimethyl-2-imidazolidinylidene)(3,6-
dichloro-1,2-benzenedithiolato)(o-isopropoxyphenylmethylene)ruthenium] 
 
In an argon filled glovebox, C642 (0.150 g, 0.234 mmol) and (3,6-dichlorobenzene-1,2-
dithiolato)(ethylenediamine)zinc(II) (0.086 g, 0.26 mmol) were combined in a 20 mL 
scintillation vial equipped with a  magnetic stirbar and dissolved in tetrahydrofuran (10 mL). The 
reaction was stirred for 60 minutes then devolatilized, redissolved in dichloromethane, filtered, 
S9 
 
and recrystallized from dichloromethane/diethyl ether at -35 ºC. The resulting yellow/brown 
crystals were washed with cold diethyl ether (2 x 3 mL) then dried in vacuo to afford 4 (0.128 g, 
70.2% yield).   
 
1
H NMR (400 MHz, CD2Cl2) [two conformers in solution, 40:60] δ 14.52 br s (0.4H), 14.43 (br 
s, 0.6H), 7.33 (t, J = 7.4 Hz, 1H), 7.08 (d, J = 8.4 Hz, 1H), 7.05-6.67 (m, 9H), 6.13 (br s, 1H), 
5.42 (br s, 1H), 3.94 (br q, J = 8.0 Hz, 1.2H), 3.78 (br s, 0.8H), 1.88-1.74 (m, 6H), 1.50-1.28 (m, 
6H). 
19
F NMR (376 MHz, CD2Cl2) (peak list) δ -100.7, -108.5 (broad), -111.9, -113.1, -115.2 (broad), 
-116.7, -117.9, -121.8. 
HRMS (FAB+): [M]
+
 C33H28Cl
37
ClF4N2ORuS2 Calculated – 781.9971, Found – 781.9982 
 
Table 1: Self-Metathesis of 5-Tetradecene 
In an argon filled glovebox, a 20 mL scintillation vial equipped with a magnetic stirbar was 
charged with C765 (4.5 mg, 0.0059 mmol) and tetrahydrofuran (1 mL). 5-tetradecene (cis or 
trans) (0.150 mL, 0.588 mmol) was subsequently added, the vial sealed and heated to 40 ºC for 2 
hours. Yields and stereoselectivies were determined by gas chromatography (method 1). 
 
Table 2: Self-Metathesis of Methyl Oleate 
In an argon filled glovebox, a 20 mL scintillation vial equipped with a magnetic stirbar was 
charged with either C765 (0.5-7.5 mol %) or C849z (0.01 mol %) and tetrahydrofuran (1 mL). 
Methyl-9-octadecenoate (cis or trans) (0.150 mL, 0.442 mmol) was subsequently added, the vial 
sealed and stirred at ambient temperature. Reactions were sampled at appropriate time intervals 
and yields/stereoselectivies were determined by gas chromatography (method 2). 
 
Table 2, Entry 1 [isolated yield]: 
In an argon filled glovebox, a 20 mL scintillation vial equipped with a magnetic stirbar was 
charged with C849z (0.8 mg, 0.09 mol, 0.01 mol %) and tetrahydrofuran (2 mL). Methyl cis-9-
octadecenoate (0.300 mL, 0.88 mmol) was subsequently added, the vial sealed and stirred at 
ambient temperature for 2 hours. The reaction was directly adsorbed onto silica gel and purified 
by column chromatography eluting with a gradient of 05% ethyl acetate in hexanes. All three 
reaction products were isolated as colorless oils. 
 
 
Methyl cis-9-octadecenoate: 132.3 mg, 50.7% yield 
1
H NMR (400 MHz, CDCl3) δ 5.38-5.26 (m, 2H), 3.64 (s, 3H), 2.27 (t, J = 7.5 Hz, 2H), 2.04-
1.93 (m, 4H), 1.66-1.53 (m, 2H), 1.37-1.20 (m, 20H), 0.86 (t, J = 6.7 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 174.3, 130.1, 129.8, 51.5, 34.2, 32.0, 29.9, 29.8, 29.6, 29.4, 29.4, 
29.3, 29.2, 29.2, 27.3, 27.3, 25.1, 22.8, 14.2. 
 
 
(Z)-octadec-9-ene: 53.6 mg, 24.1% yield 
1
H NMR (400 MHz, CDCl3) δ 5.46-5.27 (m, 2H), 2.02 (dd, J = 12.1, 6.4 Hz, 4H), 1.40-1.22 (m, 
24H), 0.89 (t, J = 6.8 Hz, 6H). 
13
C NMR (101 MHz, CDCl3) δ 130.1, 32.1, 30.0, 29.7, 29.5, 29.5, 27.4, 22.9, 14.3. 
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(Z)-dimethyl octadec-9-enedioate: 73.2 mg, 24.4% yield 
1
H NMR (400 MHz, CDCl3) δ 5.37-5.22 (m, 2H), 3.63 (s, 6H), 2.27 (t, J = 7.5 Hz, 4H), 2.04-
1.91 (m, 4H), 1.65-1.51 (m, 4H), 1.35-1.22 (m, 16H). 
13
C NMR (101 MHz, CDCl3) δ 174.3, 129.9, 51.5, 34.2, 29.7, 29.2, 29.2, 29.2, 27.2, 25.0. 
 
Table 2, Entry 7 [isolated yield]: 
In an argon filled glovebox, a 20 mL scintillation vial equipped with a magnetic stirbar was 
charged with C765 (50.7 mg, 0.0663 mmol, 7.5 mol %) and tetrahydrofuran (2 mL). Methyl 
trans-9-octadecenoate (0.300 mL, 0.884 mmol) was subsequently added, the vial sealed and 
stirred at ambient temperature for 20 hours. The reaction was directly adsorbed onto silica gel 
and purified by column chromatography eluting with a gradient of 05% ethyl acetate in 
hexanes. All three reaction products were isolated as colorless oils. 
 
 
Methyl trans-9-octadecenoate: 132.0 mg, 50.6% yield 
1
H NMR (400 MHz, CDCl3) δ 5.45-5.27 (m, 2H), 3.63 (s, 3H), 2.27 (t, J = 7.5 Hz, 2H), 1.99-
1.89 (m, 4H), 1.68-1.51 (m, 2H), 1.34-1.19 (m, 20H), 0.86 (t, J = 6.7 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 174.3, 130.5, 130.3, 51.4, 34.2, 32.7, 32.7, 32.0, 29.8, 29.7, 29.6, 
29.4, 29.3, 29.2, 29.2, 29.0, 25.1, 22.8, 14.2. 
 
 
(E)-octadec-9-ene: 53.8 mg, 24.2% yield 
1
H NMR (400 MHz, CDCl3) δ 5.46-5.33 (m, 1H), 1.97 (dd, J = 10.7, 5.9 Hz, 4H), 1.40-1.13 (m, 
24H), 0.89 (t, J = 6.8 Hz, 6H). 
13
C NMR (101 MHz, CDCl3) δ 130.5, 32.8, 32.1, 29.9, 29.7, 29.5, 29.4, 22.9, 14.3. 
 
 
(E)-dimethyl octadec-9-enedioate: 72.6 mg, 24.2% yield 
1
H NMR (400 MHz, CDCl3) δ 5.41-5.27 (m, 2H), 3.63 (s, 6H), 2.27 (t, J = 7.5 Hz, 4H), 1.98-
1.88 (m, 4H), 1.65-1.50 (m, 4H), 1.34-1.21 (m, 16H). 
13
C NMR (101 MHz, CDCl3) δ 174.3, 130.4, 51.5, 34.2, 32.6, 29.6, 29.2, 29.2, 29.0, 25.0. 
 
Table 3: Cross Metathesis of 4-Octene and 1,4-Diacetoxy-2-Butene 
In an argon filled glovebox, a 20 mL scintillation vial equipped with a magnetic stirbar was 
charged with catalyst and tetrahydrofuran (0.50 mL). 4-Octene (0.100 mL, 0.64 mmol) and 1,4-
diacetoxy-2-butene (0.406 mL, 2.55 mmol) were subsequently added, the vial sealed and stirred 
at ambient temperature. Reactions were sampled at appropriate time intervals and 
yields/stereoselectivies were determined by gas chromatography (method 2). 
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Table 3, Entry 1 [isolated yield]: 
In an argon filled glovebox, a 20 mL scintillation vial equipped with a magnetic stirbar was 
charged with C765 (14.6 mg, 0.0191 mmol, 3 mol %) and tetrahydrofuran (0.5 mL). Cis-4-
octene (0.100 mL, 0.636 mmol) and cis-1,4-diacetoxy-2-butene (0.406 mL, 2.55 mmol) were 
subsequently added, the vial sealed and stirred at ambient temperature for 5 hours. The reaction 
was directly adsorbed onto silica gel and purified by column chromatography eluting with a 
gradient of 05% ethyl acetate in hexanes to afford (Z)-hex-2-en-1-yl acetate (74.6 mg, 0.525 
mmol, 82.5% yield) as a colorless oil.  
 
 
1
H NMR (400 MHz, CDCl3) δ 5.69-5.44 (m, 2H), 4.59 (d, J = 6.8 Hz, 2H), 2.11-1.96 (m, 5H), 
1.44-1.32 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 171.0, 135.2, 123.6, 60.5, 29.6, 22.6, 21.0, 13.7. 
 
Table 3, Entry 3 [isolated yield]: 
In an argon filled glovebox, a 20 mL scintillation vial equipped with a magnetic stirbar was 
charged with C765 (36.5 mg, 0.0477 mmol, 7.5 mol %) and tetrahydrofuran (0.5 mL). Trans-4-
octene (0.100 mL, 0.636 mmol) and trans-1,4-diacetoxy-2-butene (0.406 mL, 2.55 mmol) were 
subsequently added, the vial sealed and stirred at ambient temperature for 5 hours. The reaction 
was directly adsorbed onto silica gel and purified by column chromatography eluting with a 
gradient of 05% ethyl acetate in hexanes to afford (E)-hex-2-en-1-yl acetate (22.8 mg, 0.160 
mmol, 25.2% yield) as a colorless oil.  
 
 
1
H NMR (400 MHz, CDCl3) δ 5.81-5.52 (m, 2H), 4.50 (d, J = 6.7 Hz, 2H), 2.09-1.95 (m, 5H), 
1.45-1.35 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 171.0, 135.3, 123.5, 66.7, 35.6, 22.7, 21.1, 13.7. 
 
Table 4: Cross Metathesis of trans-4-Octene and trans-1,4-Diacetoxy-2-Butene 
In an argon filled glovebox, a 4 mL scintillation vial equipped with a magnetic stirbar was 
charged with catalyst and tetrahydrofuran (1 mL). Trans-4-octene (0.050 mL, 0.32 mmol) and 
trans-1,4-diacetoxy-2-butene (0.203 mL, 1.27 mmol) were subsequently added, the vial sealed 
and stirred at ambient temperature. Reactions were sampled at appropriate time intervals and 
yields/stereoselectivies were determined by gas chromatography (method 2). 
 
Table 5: Cross Metathesis of 1-Decene and 4-Octene 
In an argon filled glovebox, a 4 mL scintillation vial equipped with a magnetic stirbar was 
charged with catalyst and tetrahydrofuran (2 mL). 4-Octene (cis or trans) (0.125 mL, 0.79 mmol) 
and 1-decene (0.050 mL, 0.26 mmol) were subsequently added, the vial sealed and stirred at 
ambient temperature. Reactions were sampled at appropriate time intervals and 
yields/stereoselectivies were determined by gas chromatography (method 1). 
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GC Methods 
 
Volatile products were analyzed using an Agilent 6850 gas chromatography (GC) instrument 
with a flame ionization detector (FID). The following conditions and equipment were used: 
 
Method 1 
 
Column: DB-225, 30m x 0.25mm (ID) x 0.25μm film thickness.  
Manufacturer: Agilent 
GC and column conditions: Injector temperature: 220 ºC, Detector temperature: 220 ºC 
Oven temperature: Starting temperature: 35 ºC, hold time: 0.5 minutes.          
                               Ramp rate 10 ºC/min to 130 ºC, hold time: 0 minutes.                                                                                                               
                               Ramp rate 20 ºC/min to 220 ºC, hold time: 5 minutes. 
Carrier gas: Helium 
Mean gas velocity: 25 cm/sec 
Split ratio: 20:1 
 
 
Method 2 
 
Column: HP-5, 30m x 0.25mm (ID) x 0.25μm film thickness.  
Manufacturer: Agilent 
GC and column conditions: Injector temperature: 250 ºC, Detector temperature: 280 ºC 
Oven temperature: Starting temperature: 100 ºC, hold time: 1 minute          
                               Ramp rate 10 ºC/min to 270 ºC, hold time: 12 minutes.                                                                                                               
Carrier gas: Helium 
Average velocity: 30 cm/sec 
Split ratio: 40.8:1 
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Figure S1. 
1
H NMR (400 MHz, CD2Cl2) of 2 
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Figure S2. 
13
C NMR (101 MHz, CD2Cl2) of 2 
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Figure S3. 
1
H NMR (400 MHz, DMSO-d6) of N
1
,N
2
-bis(2-fluoro-6-methylphenyl)oxalamide 
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Figure S4. 
13
C NMR (101 MHz, DMSO-d6) of N
1
,N
2
-bis(2-fluoro-6-methylphenyl)oxalamide 
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Figure S5. 
19
F NMR (376 MHz, DMSO-d6) of N
1
,N
2
-bis(2-fluoro-6-methylphenyl)oxalamide 
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Figure S6. 
1
H NMR (400 MHz, DMSO-d6) of 1,3-bis(2-fluoro-6-methylphenyl)-4,5-dihydro-
1H-imidazol-3-ium chloride  
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Figure S7. 
13
C NMR (101 MHz, DMSO-d6) of 1,3-bis(2-fluoro-6-methylphenyl)-4,5-dihydro-
1H-imidazol-3-ium chloride  
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Figure S8. 
19
F NMR (376 MHz, DMSO-d6) of 1,3-bis(2-fluoro-6-methylphenyl)-4,5-dihydro-
1H-imidazol-3-ium chloride  
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Figure S9. 
1
H NMR (400 MHz, CD2Cl2) of C829  
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Figure S10. 
31
P NMR (162 MHz, CD2Cl2) of C829  
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Figure S11. 
19
F NMR (376 MHz, CD2Cl2) of C829  
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Figure S12. 
1
H NMR (400 MHz, CD2Cl2) of 3  
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Figure S13. 
19
F NMR (376 MHz, CD2Cl2) of 3  
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Figure S14. 
1
H NMR (400 MHz, DMSO-d6) of N,N'-bis(2,6-difluorophenyl)formimidamide  
S28 
 
 
Figure S15. 
19
F NMR (376 MHz, DMSO-d6) of N,N'-bis(2,6-difluorophenyl)formimidamide  
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Figure S16. 
1
H NMR (400 MHz, DMSO-d6) of 1,3-bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-
dihydro-1H-imidazol-3-ium tetrafluoroborate  
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Figure S17. 
13
C NMR (101 MHz, DMSO-d6) of 1,3-bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-
dihydro-1H-imidazol-3-ium tetrafluoroborate  
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Figure S18. 
19
F NMR (376 MHz, DMSO-d6) of 1,3-bis(2,6-difluorophenyl)-4,4-dimethyl-4,5-
dihydro-1H-imidazol-3-ium tetrafluoroborate  
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Figure S19. 
1
H NMR (400 MHz, CD2Cl2) of C642  
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Figure S20. 
19
F NMR (376 MHz, CD2Cl2) of C642  
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Figure S21. 
1
H NMR (400 MHz, CD2Cl2) of 4  
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Figure S22. 
19
F NMR (376 MHz, CD2Cl2) of 4  
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Figure S23. 
1
H NMR (400 MHz, CDCl3) of Methyl cis-9-octadecenoate  
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Figure S24. 
13
C NMR (101 MHz, CDCl3) of Methyl cis-9-octadecenoate  
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Figure S25. 
1
H NMR (400 MHz, CDCl3) of (Z)-octadec-9-ene  
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Figure S26. 
13
C NMR (101 MHz, CDCl3) of (Z)-octadec-9-ene  
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Figure S27. 
1
H NMR (400 MHz, CDCl3) of (Z)-dimethyl octadec-9-enedioate  
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Figure S28. 
13
C NMR (101 MHz, CDCl3) of (Z)-dimethyl octadec-9-enedioate  
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Figure S29. 
1
H NMR (400 MHz, CDCl3) of Methyl trans-9-octadecenoate  
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Figure S30. 
13
C NMR (101 MHz, CDCl3) of Methyl trans-9-octadecenoate  
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Figure S31. 
1
H NMR (400 MHz, CDCl3) of (E)-octadec-9-ene  
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Figure S32. 
13
C NMR (101 MHz, CDCl3) of (E)-octadec-9-ene  
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Figure S33. 
1
H NMR (400 MHz, CDCl3) of (E)-dimethyl octadec-9-enedioate  
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Figure S34. 
13
C NMR (101 MHz, CDCl3) of (E)-dimethyl octadec-9-enedioate  
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Figure S35. 
1
H NMR (400 MHz, CDCl3) of (Z)-hex-2-en-1-yl acetate 
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Figure S36. 
13
C NMR (101 MHz, CDCl3) of (Z)-hex-2-en-1-yl acetate  
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Figure S37. 
1
H NMR (400 MHz, CDCl3) of (E)-hex-2-en-1-yl acetate  
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Figure S38. 
13
C NMR (101 MHz, CDCl3) of (E)-hex-2-en-1-yl acetate  
 
